Novo Nordisk
NVO
#78
Rank
HK$1.616 T
Marketcap
HK$363.84
Share price
-2.28%
Change (1 day)
-57.22%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Novo Nordisk (NVO) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : HK$418.83 Billion

According to Novo Nordisk's latest financial reports the company's total liabilities are HK$418.83 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Novo Nordisk - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31HK$349.14 B45.17%
2023-12-31HK$240.50 B35.48%
2022-12-31HK$177.51 B20.82%
2021-12-31HK$146.92 B40.52%
2020-12-31HK$104.56 B31.65%
2019-12-31HK$79.42 B12.34%
2018-12-31HK$70.70 B6.84%
2017-12-31HK$66.17 B15.31%
2016-12-31HK$57.39 B12.71%
2015-12-31HK$50.91 B9.32%
2014-12-31HK$46.57 B16.84%
2013-12-31HK$39.86 B15.85%
2012-12-31HK$34.41 B-6.67%
2011-12-31HK$36.87 B8.64%
2010-12-31HK$33.93 B19.54%
2009-12-31HK$28.39 B10.74%
2008-12-31HK$25.63 B7.9%
2007-12-31HK$23.76 B18.28%
2006-12-31HK$20.08 B14.41%
2005-12-31HK$17.55 B12.75%
2004-12-31HK$15.57 B29.2%
2003-12-31HK$12.05 B16.5%
2002-12-31HK$10.34 B-2.16%
2001-12-31HK$10.57 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
HK$899.57 B 114.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$708.58 B 69.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$609.04 B 45.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$513.65 B 22.64%๐Ÿ‡ซ๐Ÿ‡ท France